trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'bcsm', 'breast']
today #asco22 is excited about trastuzumab deruxtecan but i have dr andre iibawi s words from yesterday in my ears - nearly 25 years after fda approval of trastuzumab it is *still* only available to a third of global breast cancer patients
#bcsm
#NHS Oncologist, @UHSussex Macmillan National Clinical Adviser, #radonc #BHAFC #gerionc (He/Him) #Brighton pic by @FinnHop